Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.QuantRx Biomedical has concluded the development of the Fieldtests ID product line for identifying drugs-of-abuse residue and has entered into an exclusive manufacturing agreement with Fieldtests.
Subscribe to our email newsletter
Fieldtests has also agreed to distribute company’s QuikSense Drugs-of-Abuse products through its distribution channels, and intends to add other QuantRx products, such as RapidSense and OralSense, as they are introduced to the market. The new product is scheduled for launch in the second quarter of 2008.
These new products are said to represent a break-through technology for the field-testing of narcotic residues in both the law enforcement and occupational health marketplace.
Len Jonker, president of Fieldtests, said: “QuantRx will be our exclusive manufacturer for this product which allows us to introduce a new paradigm in the field-testing of narcotics. Initial feedback from law enforcement agents indicates a dramatic improvement to the current available products.”